Skip to main content
. Author manuscript; available in PMC: 2024 Jul 1.
Published in final edited form as: J Thorac Cardiovasc Surg. 2022 Sep 18;166(1):e5–e14. doi: 10.1016/j.jtcvs.2022.09.019

Table 1:

Angiogenic protein expression in ischemic myocardium of EV-treated swine.

Protein Median (IQR) P Value

Anti-Angiogenic
Angiostatin 0.75 (0.71–0.79) <0.001
Endostatin 0.41 (0.33–0.79) 0.043
DLL4 0.76 (0.66–1.02) 0.95
Pro-Angiogenic
Angiopoietin 1 1.31 (1.11–1.45) 0.14
β-Catenin 1.09 (0.56–1.44) 0.66
VE-Cadherin 0.67 (0.44–0.76) 0.28
Tie2 0.82 (0.59–0.99) 0.29
VEGF-A 0.62 (0.37–0.95) 0.14
FGFR1 0.91 (0.83–1.00) 1
MCP-1 1.07 (0.92–1.10) 0.85

Statistics presented as median fold change (interquartile range) of protein level in metabolic syndrome pigs treated with extracellular vesicles (HVM, n=8) compared to control (n=6). P values calculated using Wilcoxon rank sum test. DLL4, delta like ligand 4; VEGF-A, vascular endothelial growth factor A; FGFR1, fibroblast growth factor receptor 1; MCP-1, monocyte chemoattractant protein 1.